Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 130 results for "biocon"

Top pharma cos overcharging, NPPA lists 634 drugs for breachin...

NPPA has named Sun Pharma, Cipla, Lupin, Abbott, Biocon, Wockhardt, others Business Standard, 4 hours ago

185 images for biocon

Business Standard, 1 week ago
Money Control, 2 weeks ago
Canadian Biomass Magazine, 3 weeks ago
Livemint.com, 3 weeks ago
DealStreetAsia, 3 weeks ago
Financial Express, 3 weeks ago
ABC News, 3 weeks ago
Livemint.com, 1 month ago
Livemint.com, 1 month ago
Odisha Television, 1 month ago

According to Biocon and Mylan, their respective breast

Biocon and Mylan have taken the stand that Roche no longer holds a patent in India for Trastuzumab.
 DNA5 days ago Can Biocon, Mylan drugs be used for early breast cancer: HC  DNA1 week ago

S&P BSE 500, Nifty Midcap 100 index hit record highs

Total 12 stocks include Biocon, Alkem Lab, SJVN, Aarti Ind, Dilip Buildcon and Motilal Oswal Fin hit record highs.
 Business Standard1 week ago S&P BSE 500 index hits record high  Business Standard1 week ago
Business Standard

Biocon and Mylan get USFDA approval to jointly develop biologic product

The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace The post Biocon and Mylan get USFDA approval to jointly develop biologic product appeared first on Firstpost .
 First Post.com1 week ago US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim  Business Standard1 week ago USFDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  Business Standard1 week ago FDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  DNA1 week ago

USFDA accepts Mylan's application for proposed biosimilar

The Bengaluru-based Biocon and its partner Mylan Inc today said US drug regulator USFDA has accepted Mylan's biologics licence application (BLA) for a proposed biosimilar of branded trastuzumab for treatment of certain breast and gastric cancers.
 DNA1 week ago Biocon scales record high as USFDA accepts BLA for proposed biosimilar Trastuzumab  Business Standard1 month ago USFDA to review Biocon-Mylan's biosimilar drug for breast cancer  Money Control1 month ago USFDA accepts Biocon cancer drug biosimilar application  Business Standard1 month ago

Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim

Biocon shares gained 2.6 percent to hit a record high of Rs 1,123 after the US health regulator USFDA has accepted pharma major Mylan's biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim.
 Money Control1 week ago Biocon hits new high after USFDA accepts cancer drug biosimilar application  Business Standard1 month ago Biocon at new high as USFDA accepts application for cancer drug  Money Control1 month ago

Biocon chief sees anti-cancer biosimilar launch in FY19

Biocon Thursday announced the US Food and Drug Administration has accepted Mylan’s Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and ...
 Money Control1 week ago US nod for Biocon-Mylan biosimilar  Business Line1 month ago Biosimilar developed by Biocon, Mylan  Business Line2 months ago Biocon proposed Biosimilar developed by Mylan and Company  India Infoline2 months ago

Top buzzing midcap stocks to trade on February 17

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- HDFC Bank, Cadila, Havells, Biocon, Greaves Cotton and Symphony.
 Money Control1 week ago

Ban open burning of all wastes, says Biocon's Kiran Mazumdar-Shaw

Mazumdar-Shaw said air pollution is a serious hazard which has already taken its toll in Delhi
 Business Standard1 week ago

Dream run for midcaps with all time highs

Small and midcap stocks are on a roll as institutional and retail investors are making big bets on these stocks, some of which have hit lifetime highs. Both the small and mid cap indices, which are currently at new all-time highs, have outperformed benchmark ...
 The Financial Chronicle6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less